Double Blind Randomized Placebo-controlled Multicenter Study to Evaluate Clinical Efficacy and Safety of Ingavirin, Capsules 30 mg, in 3-6 Years Old Patients With Influenza and Other Acute Respiratory Viral Infections in the Course of Standard Therapy
Phase of Trial: Phase III
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Myelo 001 (Primary)
- Indications Viral infections
- Focus Therapeutic Use
- Acronyms ACCORD
- Sponsors Valenta Pharmaceuticals
- 07 Jun 2016 Status changed from recruiting to completed.
- 28 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 11 Jan 2016 New trial record